Mega CapHealthcareDividend

ABBV — AbbVie Inc.

Pharmaceuticals · Founded 2013 · North Chicago, Illinois · CEO: Robert Michael

AbbVie is a global biopharmaceutical company focused on immunology, oncology, neuroscience, and eye care. Spun off from Abbott Laboratories in 2013, AbbVie is best known for Humira (the world's best-selling drug of all time) and its successor drugs Skyrizi and Rinvoq.

How AbbVie Inc. Makes Money

Immunology franchise (Skyrizi, Rinvoq replacing Humira revenue)

Oncology portfolio (Imbruvica, Venclexta, and pipeline assets)

Neuroscience (Botox, Vraylar) from Allergan acquisition

Eye care (Restasis, Vuity) and aesthetics (Juvederm, CoolSculpting)

Key Metrics Investors Watch

Skyrizi and Rinvoq revenue growth (Humira replacement trajectory)
Humira erosion rate from biosimilar competition
Pipeline clinical trial readouts and regulatory approvals
Adjusted EPS growth
Dividend payout and free cash flow coverage

Competitive Advantages

Skyrizi and Rinvoq are becoming the next-generation immunology blockbusters, successfully replacing Humira revenue
Diversified portfolio across immunology, oncology, neuroscience, and aesthetics reduces concentration risk
Strong pipeline with multiple drugs in late-stage clinical trials
Generous and growing dividend supported by strong cash flow generation

Key Risks

Humira biosimilar competition causing revenue decline in the legacy franchise
Pipeline clinical trial failures could impact growth outlook
Drug pricing reform legislation targeting pharmaceutical industry
Integration challenges from the large Allergan acquisition

Dividend & Capital Return

AbbVie pays one of the most generous dividends in the pharmaceutical sector and has increased its dividend every year since its spin-off, including continuation of Abbott's prior streak as a Dividend Aristocrat.

I Document Every Trade — Even the Losses

Options record: 1W-8L. Net worth: 100% GSE preferred. Get the unfiltered updates.

Unsubscribe anytime. I respect your inbox more than Congress respects property rights.

Frequently Asked Questions

Is AbbVie stock a good investment?

AbbVie offers a high dividend yield, a growing immunology franchise (Skyrizi/Rinvoq), and diversification across multiple therapeutic areas. The key question is how successfully it navigates the Humira patent cliff. This is educational content, not financial advice.

What happened to Humira?

Humira lost US patent exclusivity in 2023, enabling biosimilar competition that is eroding revenue. AbbVie has positioned Skyrizi and Rinvoq as successor drugs to offset the decline.

Does AbbVie pay a dividend?

Yes, AbbVie pays a generous quarterly dividend and has increased it every year since the company's spin-off from Abbott in 2013. It carries Dividend Aristocrat status.

What are Skyrizi and Rinvoq?

Skyrizi and Rinvoq are AbbVie's next-generation immunology drugs targeting psoriasis, Crohn's disease, ulcerative colitis, and rheumatoid arthritis. They are growing rapidly and are expected to collectively surpass Humira's peak revenue.

What are the risks to AbbVie stock?

Key risks include faster-than-expected Humira erosion, clinical trial setbacks in the pipeline, drug pricing reform, and Allergan integration challenges.

Related Stocks

JNJ

Johnson & Johnson

Healthcare

Johnson & Johnson is a global healthcare company operating in pharmaceuticals (Innovative Medicine) and medical devices (MedTech). Following the spin-off of its consumer health division as Kenvue in 2023, JNJ is now focused on higher-growth, higher-margin healthcare segments.

MRK

Merck & Co., Inc.

Healthcare

Merck is a global pharmaceutical and animal health company known for Keytruda, the world's best-selling cancer immunotherapy drug. The company has a strong pipeline in oncology, vaccines, and cardiometabolic diseases and operates one of the largest animal health businesses globally.

LLY

Eli Lilly and Company

Healthcare

Eli Lilly is a global pharmaceutical company at the center of the GLP-1 / obesity drug revolution. Mounjaro (tirzepatide) for diabetes and Zepbound for weight loss have made Lilly one of the fastest-growing and most valuable pharmaceutical companies in the world.

PFE

Pfizer Inc.

Healthcare

Pfizer is one of the world's largest pharmaceutical companies, with a diversified portfolio spanning oncology, immunology, rare diseases, vaccines, and hospital medicines. The company became globally prominent during the COVID-19 pandemic through its co-developed mRNA vaccine (Comirnaty) with BioNTech and antiviral pill Paxlovid. Post-pandemic, Pfizer has focused on restoring growth through acquisitions including Seagen (oncology) and deploying its substantial cash reserves. The company faces significant patent cliffs on several major drugs in the late 2020s.

Recommended Resources

Tools & books I actually use and recommend

SeekingAlpha Premium

Quant ratings, earnings transcripts, and the stock analysis community where I published 300+ articles.

Try SeekingAlpha

The Intelligent Investor

Ben Graham's timeless guide to value investing. The book Warren Buffett calls "the best investing book ever written."

View on Amazon

Interactive Brokers

Low commissions, global market access, and professional-grade tools. This is where I hold my positions.

Open an Account

Some links above are affiliate links. I only recommend products I personally use. See my full disclosures.

Keep Exploring

Hub

All Stocks

Browse all 134 stock profiles by sector.

Best Stocks For Beginners

Curated stock picks for new investors by goal.

Financial Glossary

Understand the terms investors use every day.

Stock vs ETF

Individual stocks vs ETFs — which is right for you?

ETF Profiles

Deep dives on 90+ ETFs across every category.

Buying Your First Stock

How to open a brokerage and buy your first share.

Browse All 134 Stock Profiles

Company information is based on publicly available disclosures and widely-known business facts. No specific price, earnings, or real-time market data is included. This is educational content — not investment advice.